Adagrasib + SRS for Patients With Metastatic KRAS G12C-mutated NSCLC With Untreated Brain Metastases
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to NSCLC
Related studies linked through entity extraction aliases.
Korean Registry of Non-Small Cell Lung Cancer Patients with EGFR Mutation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
A Phase 2 Study of EIK1001 in Combo With Pembrolizumab and Chemotherapy in Patients With Stage 4 NSCLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
ERK Inhibitor JSI-1187 in Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Toripalimab Therapy After Resection in High-risk Stage IA2-IB NSCLC With no Driver Alterations (EGFR or ALK)
- Status
- RECRUITING
- Phase
- PHASE2
Immuno-pet IMaging ResPonses AdministeRed Immune CheckpoiNt InhibiTor
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2/PHASE3
Stereotactic Ablative Radiotherapy in Synchronous and Metachronous Oligo-Metastatic Non Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- NA
A Study of Sunvozertinib Combined With Anlotinib in Local Advanced or Metastatic Non-small Cell Lung Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
RecistTM Criteria in Evaluating the Efficacy of Targeted Therapy for NSCLC
- Status
- RECRUITING
- Phase
- N/A
Online Adaptive Radiotherapy Using a Novel Linear Accelerator (ETHOS)
- Status
- RECRUITING
- Phase
- N/A
A Study of Local Envafolimab Injection Combined With Chemotherapy in Non-small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Study of YL202 in Selected Patients With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE2
Safety and Efficacy of NK510 to Treat NSCLC
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Efficacy and Safety of Neoantigen Peptide Vaccine in the Treatment of Advanced NSCLC Progressed After EGFR-TKI Treatment
- Status
- RECRUITING
- Phase
- NA
A Study of BMS-986315 and Nivolumab in Combination With Chemotherapy in Participants With First-line Stage IV or Recurrent Non-small Cell Lung Cancer (NSCLC)
- Status
- TERMINATED
- Phase
- PHASE2
Milademetan in Combination With Atezolizumab in Patients With Advanced Solid Tumors With CDKN2A Loss
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Significance of MRD Monitoring in Patients With Potentially Resectable Stage III Non-small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- N/A
Study of EGFR TKI in Patients With Advanced NSCLC Harbouring EGFR Mutations
- Status
- RECRUITING
- Phase
- PHASE2
Neoadjuvant and Adjuvant Targeted Treatment in NSCLC With BRAF V600 or MET Exon 14 Mutations
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2